Acquisition (code A) of 62,500 shares at $0.00 per share.
Reporting Person Sullivan Mark · Officer Title Chief Legal Officer · Transaction Code A
Traded Aug 12, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001193125-26-345837 · filed 2026-08-12 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Definium Therapeutics, Inc. (DFTX)." Disclosed 2026-08-12. https://desqlong.com/cards/0001193125-26-345837-1 (retrieved 2026-09-26).